Basic information Region (hg38): 15:24978583-25420336
Previous symbols: [
"UBE3A-AS1"
]
Links ENSG00000224078 ∙ NCBI:104472715 ∙ OMIM:616259 ∙ HGNC:37462 ∙ ∙ ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar Phenotypes GenCC Source: genCC
No genCC data.
ClinVar This is a list of variants' phenotypes submitted to ClinVar and linked to the SNHG14 gene.
Angelman syndrome (547 variants) not provided (257 variants) Inborn genetic diseases (67 variants) not specified (65 variants) UBE3A-related condition (10 variants) Intellectual disability (6 variants) See cases (4 variants) - (2 variants) Epileptic encephalopathy (1 variants) Developmental disorder (1 variants) Neurodevelopmental disorder (1 variants) Developmental delay;Intellectual disability (1 variants) Autism (1 variants) 6 conditions (1 variants) Normal pregnancy (1 variants) Variants pathogenicity by type Statistics on ClinVar variants can assist in determining whether a specific variant type in the SNHG14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum synonymous 0 missense 0 nonsense 0 start loss 0 frameshift 0 inframe indel 0 splice donor/acceptor (+/-2bp) 0 splice region ?
0 non coding ?
172 63 282 206 32 755 Total 172 63 282 206 32
Variants in SNHG14 This is a list of pathogenic ClinVar variants found in the SNHG14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position Type Phenotype Significance ClinVar 15-24986947-T-A Uncertain significance (Oct 01, 2023) 2645012 15-25175830-CTAGCTGTTGGACTCGTGGGCTTTGGGCCAGTGGGGCAGCCTGCATCCCTCTGGAAGTCACCCCTTCCCTGTGGCTGGAAGTTACCCCTTCCCAGTGGGCGAATGTGGGGAAGGGTCACCTCCTGAAGTGAGAAGGCCCACTATTGAGGGTCCTGTCCTGGCAATTTGCTGCCCATGCTGCTTCTGAGCCATGGAGACACCTCCAGTGTGGTGGGATCTTGGGCCCAAGGAAGGGAGAAGACACTGTGCCCCCCGATTAGCTGAGTGTGGCCAGGCTGTGTGTTTATGAGGTGTGAGGGGCATGGATGGAAACTCACCAGAGAAAGCATGTGGCCCTGGGACCCCAGGTCGTGGTTTCCAGTATGTGCCCAGATACAGCACATGGGTGGGTGCCCACCATGCACAGGGACTGGCTATGTGACTGCCAGCTGTGCAGCAGCATCAGGCATATGGGCCAGCCTCCTTGGTTGACAATGAACTGGTTGCTGGCCCTGGCCTGTGCCCAGTAGTCCTGGGGTGACCCTGGTGTCATACAGGGGAGCTGGCATGTGTAGTGGAGGTGCTTGTGGGGCTTGCAGTAGGGCACAGCCCTGGCTTCTAGCCTGAGCCCAGTGACCTGCCTGTCCTATCCTTTCGGTGTTCAGTGGCGGAGAGAGCATTGGGTGCCCTGCATCCATGATGGGTAAGTATTCCACATGGATCTCATCACATGGGTCCATGGAAGGTGAGCATCCCTGAGCTGGCACACCACACCTTCTGTCCACATGGAGGGGTGAGGTTGTGTTTGGGCACTTGTCCTCTTCCTGTTCCTTGAGATGGTGACCCCAGAGGAGGACATGCGTTGGGCCCGCTGTCCCTGGCCAGTGGCCATCAGCCAAGTGCCTAGCCCCTATTGCACTGAAACTCGGGCCCTTCCTGTCACCTTGGTCTCCTGCGTTGAGCTTGGGTGAGCCCATCCGGGTGCCACTGGATGCCTAGGCAGGGAGGGGGGTGCCCTGGGTTGGGTCGATGATGAGAACTTTATATTGTTCTGAAGAGAGGTGATGACTTAAAAATCATGCTCAATAGGATTACGCTGAGGCCCAGCCTAGGTGAGAATTTTGGAAGGGGACACTAGAATCCCGAGGTCCCCAGCAGGGCTGCTGTATTTTAGGCTGGATACCTCGAGGCCCTGAAGGGCACCTCATGGAGGGGCCCAATCCTGTCTGTGCTCCTCTATTAGGCACACCAGACTTTCTGTGTGGGCTTGGTGTCCACGCTCAGCTTCCCTGGGGTGGGACACGTTGGCGGCTCCTCCGTGAGCCCCATTATCCTCTGTGTCTTTCAGTGAGCTCTTCCCCCCAGCAGACCCCTGGGATTGACGAGCATAGGTGAGTGGAGACTGCTGGTGTCATGGGCCATGAGCCAAGCTGCGTGGGGTCCCCAAGGGTCAGCCCTCGGGCCACCTGGGTTTCCTCAGGAGCTGATCTGAATCCCAACTGGGGATGTGTTCTCCAGGAGGGCAGCTTCCTTGGGAATCAGACATAAGGAGGAGGCCTTCTCTGAAGCCCCGCAGGGGTGGCAGTTGTCCAGGCAGGAAAGGGTTTCCTCAGCCCCACGCAGGGCAGTGCTCAGCTCAGACTTGGTGCTTGGGTCAGGCCTCTAACATGGCCAGGCCACATGAGGGGGGCAACAAGGGCTCCGGGGAGCCAAGGGCATCTCACGGGGGCTCTCCAACCCTGGAGAAGGGTGGGTGATTCGGTCCATGGGGTCAGGCCATGGAGATTCATGGATTGCAGCAAACCCAGGACCCTCAATGGGACTGACCCTATAAGCAGTGGGCCCTCCCAGTGGCACCTCTTTGAGCCATTTGTGGGGCGGCGCTGTTTCTCTGAGGTTGGGTCAAGACTAGCTCTGGCCAGTGCCTGATGGTGGTGCAATCCACTCCTGGGACTCGTGGGCTCTGGGCCAAGGCTGCAGCCCATGTCCCGCTGGGGGTCACCCCTTCATTGTGGGCGAGTGGCAGTAATGGCCTCCTGAGTTGGGAAGGCCCGCAGTGGAAGGACCTTTCCTGGAAATTTGCAGTCCAGGCTGCTTCTCAGCCATTAGGACAACTCCAGCGGGTTGGGGGGCAGGGGCGGGTCTTAGGCCCAAAGAAAGGAGAAGATACCATATGTCTCCCGGTTGGCTGAGTGTGGCCCTGCTGTGTGTGTGGGAGGTGTTGTGTGGGGCATGGATTGGGACACACCAGAGAAAGCTTGTGGCCCTGGAGCCCCAGGCTGCGATTTCCAGTGCACCTTGAGGAAAGGAGGGTGGGTGCCCTCCATGCACAGGGCAGACTGTGCAACTGCCAGGTAGGCAACAGCACGTGGTGTCCGGGCCAGGGTCCTTGGTTTGCTGTGAGCTCTTTGGTGTCCGTGGCCCCTACCCAAGGATCCAGATACCACCCGGGGTCATGCAGGGGAGCTAGCATGGGCAATGGAGGTGCTCAAGGGGCCTGCAGTAGGGCACAGCCCAGGTGTCTTGCCTGAGCCCAGGAACCCACCTGCCCTGTCCTTCCATGGTTCAGTGGCTGGGAGAGCAAAGGGTTCCGCTGATCTATGACACATCAGTGTTTCCCATGGATCCCATCACATGGGTCCACGGAGAGAGAGCATGTGTGAGCTGGCACCCCCAACCCCATTCCCTGTATGGAGGCGTGAGCCCATGGTTGGACACATGTCCTCCTCCTGTCCCCCCAGATGGTGACTGTGGAAGAAGACTTGCTTTGGGACCGCTGGCCCCAGGCCAGTGGTTGTCATCCAGGTGCCCAGCCCTTGGTGCACTTGAGCTCAAGCCCTTCCTGGTGCCCTGGCCTCCTGCCCTAAGCTGTGGTGAGCCCATCCAGGTCCCACTGGATGCATGCATGGGGAGGAGGGTGCCCTGGGTTGGATCGATGATGAGAACCTTATATTGTCCTGAAGAGAGGTGATGACTTAAAAATCATGCTCAATAGGATTACGCTGAGGCCCAGCCTTGGTGAGAATTTTGGAAGAGGATGCTGAGATCCCAAGGTCTCTGGCAGGGCCACTGTATTTTGGGCTGGAGACCTGGAGGCCCTGAAGGGCATCTTAGGGGTGCCCGACCCCATCTCTGCGCTCCTCCTTGAGGCAGCCCAGGCTCCCTTGCGGGCTTGGTGTCAGCCCTCCAGTTCCCTGGGGTTGAGGCACATTGGAGGCTCCTTCCTGAGCCCCCATTCTCCCCTGTGTCTTTCAGCGAGCTCTTCTGCCCAGGGGGACCCCTGGCCTTAAGTGGGATAGGTAAGTGGATCCTGCTGGGGTCGTGGACCATGAGCCAGGTCGCTTTGGGTCACTGAGAGTCACCCTTCAGGCCACGAGGGATTCCTCAGGGAGCCCATCTGAAACCCACCAGGGACGGATGGTTTCTCCAGGAGGACAGCTTCCTTGGAAGTCGGTCCCAAGAAGGATGCCTTCCCTGAAGCCGTGCAGAGATGATGGACGTCCAAGCAGGAAGGGCTTCCTTCAACTCAATGCAGTGCACATCCTAGCTGAGACTCAGTGCACAAGTCAGGCCTGGAGGACTTCCCAGGCCACATGAGGGGGTCCACAGGGTCTCCAGGGGCCACGGGTGTTATGAGGGTGCTCTCTGTCCCCGAGGCTTGCAGAGGGGCAGGGTGTGGGTGATCGGACTTATGGAGTCAGGCCGTGAAGATTCAAGGATTGGGCCCAACCCATGGCCCAGCATGGGCCGAACCTGTAGAGCAATGGGCCATCCCGGTGGTGCATCCTTGAGCCTTGTGGGGGTGGTGTGACCTTAGTGGGGTTGGGTCAAGCCTGAGCTCTGGCCTTCACCTGGTGGTGCTGCAGGCTGGCCCTGGGAATTTGGGCTTTGGGCCAAGGGTGCAGTCTGTGTCCCGCTAAAGGTCACCCCTCCCCAAAGTGGAGTGGCCAGAAGGATGGCATCCTGTGGTAGAAGTCCCACTGTCAAGGGTCCTGTCCTGGCAATTTGTTGCCCAGGCTGCTTCTAAGCCATGGGTTCACCTCCAAAGTGGCGGGGTCTTGAGCCGAAGGAAAGGGGAAGACATCATGTGTTCCCTGATTGACTGAGCATGGCCTGGCTCTGCATTTGGAGGTGTGCGGTGCACGAATGGGGACCCATCAGAGAAGGCATGTGGCCCTGGGGCTCCAGGATTTGATTTCTGGTGTGAGCTTTTACAGGGGGTCTGTAGTGGCACGTAGCATTCAGGTCAGCCTACTTGGTTTGCTCTGAGCTTGTTGGTGGTCCTGGCCCTGCCCAGTGGTCCCATTGTGGCATAGAGTCATGTGAGGGAGCTGTGGCAAGGAGGGCCAAGGGTTCCCCACATTCATGATCGTTACTGTTTACATGGATCCCATCTCTTGAGTCCATGGAGGGACAGCATGTGTGAGCCAGCACCCCCTGCCCACTTTCCTGCATGGAGGCGTGAGGCCGTATTTCTATACGTGTCCCCCACCCCTCCAGATGGTGACCCCAGAGGAAGACGTGCATTGGGTCCGCTGGCCCCAGGCCAGTGTCTCTCAGCCATGTGCTCAACACCTGGTGAGCTGAAGCTCAGGCCCTTCCTGGCATCCTGGTCTCCTGCACTGAGCTGTGGTGAGCACATCTGGGTTCCTCTGGATACGTGTGCAGGGAGGGGGATGCACTGGGTCGGGTCAATGATGAGAACCTTATATTGTTCTGAAGAGAGGTGATGACTTAAAAATCATGCTCAATAGGATTACGCTGAGGCCCAGCCTAGGTGAGAATTTTGGAAGAGGATGCTGGGATCCCAAGTTCCCCAGCATGGCCAGTATATTTTAGGCAGGAGACCCTGAGGCTCTGAACGGCATCTCCGGGGGGCACAACCCTGGCTCTGGGCTCCTCTGGGAGGCAGCCCAGGTTCCCTGTGCAGGCTTGGGCTCTGGTTCCCTGAGCCCCCATTCTCCCTCGTGTGTTTCAGTGAGCTCGTCCTCCTAGGTGGGGCCCCCAGGCATTGACCGGCATAGGTGAGTGGTCCTGCTGGGGTCATGGGTCATCAGCAGGTTGGAGTCACCAAGGGTCAGCCTTTGAGACAGGAGGGTTTCCACAGGCAGCCGACCTGAATCCACACCATGGAGGGATAGATTGGTCCTCCAAGAGGGCTGTTTTTTTTCGGAATCAGACCCAAGGAGGATACCTTCCCTGCAGCCCTGCGGGGATGACGGTGGTCCAGGCAGGGAAGGGTTCCTTCAGTCTCACGCAGGTCAGCTCCCAGCTGAGTCTCAGTGCATTGGTCTGGCCTCCAGGACTGACCAGGCCACGTGAGGGGGGCAACAGGGGCTTCGGGATGCAGTGGGGTCACACAGGATCTCTCCATCCCCAGAGAAAGGTGGGCATAGAACCCATGGATTCGAGCTGCAGAGATTCAAGAATCGCACACGAATTATTGCCCTGAATGGGACCCACCCTGTTGAGCAATGTCCCATCCCAGGGCACCTCTTTGAGCCTGAAGGGGGTGGTGCTGTTTCCCTAGGTTTGGGTCAAGGCTGAGCTCTGGCCAGTGCCTGGTGGTGCTGTAGTCCTGTCATGGACTCGTTAGCTTTACGCCAAGGGGTCAGCCCACGTCCTACTGGGGATCTCCCCTTCCCTGTGGCTGGAAGTCACCCCTTCCCCATTGGCAAGTGTCAGGAAGGGTGACCTCCTGAGGTGGAAGTCCTGTTGAGGGTCTTGTCCCTGGAATATGCCACGCATGCTGCTTCTGAGCCATGGGGTCACCTCCAGGGTAGCGGGTCTTGGGCCCAAGGAAAGGAGAAGTCACCATGTGTCCCCCGATTAGCCAAGTGCGGCCCTGCTCTGTGTTTAGGAGGTGTGTGGGGCATGGATGGGGACCCACCAGAGAAAGCATGTGGCCCAGGGACCCCAGGTTGCAATTTCTAGGACATGCTGGGATAGGGCACCTGTGTGGGTGTCCACAGTGCACAGGGATAGGCTATGTGACTTGCAGGTCTGCAGCGGCATCTGGCATCCAGGCCAGCCTCCTTGGTGGGCCGTGAACTGAATGGTGGCGCTGGCCTGTGCCCAGTATATCTGGTATGACCCTGGGGTCGTGTGGGGGAGCCGGCATGGGCAGTGGAGGTGCTTATGGGACCTGCAGTAGGACACAGTCGGGGCTTCTTGCCCAAGCCCAGTGACCCGCTTGCCCTGTCCTTCCAGGGTTCGGTGGCTGAGAGAGCTTTTGTTGCCCTGTGTCCGTGACGGGCCAGTGTTCTGCATGCATCCCATCACATGGATCCATGGAGGGTGAGCATCCCTGGGCTGACACACCCCACCTTCTGCCCCCATGGAGGGGTGAGGTTGTGTTTTCACACCTGTCTTACTCCTGTTTCCCCAGATGTTGAGCCCAGAGGAAGACTTGCACTGGGCCCAATGGCCCCAGGTCAGCGTCCATCAGCCAGGTGTCCAGCCCCTGGTGCACTGAAGATCGGGCCCTTCCTGGTGCCCTGGTCTCCTGCATTGAGCTGTGGTGAGCACATCCGGATCCTGCTGGATGCGTGTGCGGGGAAGGGGGTGCCCTGGGTTGGGTCAATGAGAACCTTATATTGTCCTGAAGAGAGGTGATAACTTAAAAATCATGCTCAATAATAGGATTACGCTGAGGCCCAGTCTAGGTGAGAGGTTTGGAAGAGGATGCTGGGATTCCGAGGTCCCCAGGAGGGCCCCTGTATTTTTGGCTGGAGACCTGGAGGCCCTGAAGGGCATCTTGTGGGTGCCCAACCCTGTCTCTGCGCTCCTCCTTGAGGCAGCCCAGGCTCCCTGTGCAGGCTTGGTGTCAGCCCTCCAGTTCCCTGGGTTTGAGGCACATGGGAAGCTCCTTTCTGAGCCCCGTTCTCCTCTTGTGTCTTTCAGTGAGCTCTTCCACATGGAAGACCCCTGTCATTGACTGGCATAGGTGAGTGGCTGGCATCATGGGCCATGAGCCAGGCCGCGTGAGGTCGCCAAGGGTCAGCCTTCGGGAAAGAAGGGTTTCCTCAGGGAGCCAACCTGAATCCCCACTGGGAAGATATGGGTTCTCCAGGAGGGCGACTTCCTGGGAAACAAGAACCAAGGAGGTCCCCTTCCCTGAAGCCCTGCAGGGGTGACGGTGGTCCAGGCAGGAAAGGGTTCCTTCAGTTCCACCCAGGGCAGCTCCCAGCTGAGGCTCGGTGCTTGCGTCTGGACTTAAGGACTGCCCTGGCCATATGAGGGGTGCCACAGTGGCTCTGGGGTGCCATGGGGTCACACAGGCACTCTCTGTCCCTGGAGAAAGGTGGGTGATTGGGCCCATGGAGTTGAGCTGTTGAGATGCAAGTTTTGCACCTGACACATGGCCCTGAATGGGACCCACCCTGTTGAGCAATGGGCCATCCCATGGGCCTCTTCGAGCCTGAAGGGGGGCGGTGCTGTTTCACTGGGTTTAGGTCAAAGCTGACCTCTGGCCGCCACCTGGTGGTGCTGCAGTCCAGCCCTTGGACTCGTGGGCTTTGGGCCAAGGGGGCAGCCTGCATCCCACTGAAAGTCACCCCTTCCCTGTGGCTGGAAGTTATCCCTTCCTCATGGGCGAGTGTTGGGAAGGGTGGCCTCCTGAAGTGGGAAGGCCCGCTATTGAGGGTCTGCTCCTGGCAATTTGCTGCCCATGCTGCTTCTGAGCCATGGAGTCACCACCAGTGTGGTGGGGTCTTGGACCCGAAGAAAGGAGAAGACACTGTGCCCCCCGATTAGCTGAGTGTGGCCAGGCTGTGTGTTTGCGAGGTGTGAAGGGCATGGATGGAGACTCACCAGAGAAAGCATGTGGCCCTGGGGCCCCAGGTTGTGGTTTCCAGTATGTGCTTGGATATGGCATATGGGTGGGTGCCTACCATGCACAGGGACTGGCTATGTGACTGCCAGCTGTGCAGCAGCATCAGGCATACGGGCCAGCCTCCTTGGTTGACCATGAACTGGTTGCTGGCCCTGGCCTGTGCCCAGTAGTCCTGGGGTGACCCTGGTGTCATGTAGGGGAGCTGGCATGTGTAGTGGAGGTGCTCGTGTGGTCTGCAGTAGGGAGCAGCCCTGGCTTCTAGCCTGAGCCCAGTGACCTGCCTGTCCTGTCCTTTCAGGGTTCAGTGGCGGAGAGAGCATCAGGTGGCCCACGTCTGTGATGGGCCAGTATTCCACATGGATCTCATCACATGGGTCCATGGAAGGCGAGCATCCCTGAGCTGGCACACCCCACCTTCTGCCAGCATGGAAGGGTGAGGTTGCATTTGGCACCTGTCCTCTTCCTGTTCCTCGAGATGGTGACCCCAGAGGAGGACTTGCATTGGGCCCACTGTCCCCGGGCCAGTGGCCATCAGCCGGGTGCCTAGCCCCTGTTGCACTGAAGCTCAGGCCCTTCCTGTTGCCCTGGTCTCCTGCATTGAGCTTGGGTGAGCCCATCCGGTTGCCACTGGATGCCTAAGCAGGGAGGGGGGTTCCCTGGGTTGGGTCAATGATGAGAACCTTACATTGTTCTGAAGAGAGATGATGACTTAAAAATCATGCTCAATAGGATTACGCTGAGGCCCAGCCTAGGTGAGAATTTTGGAAGAGGACGCTGGGATCCCTAGGTCCCTGACAGGGCCACTGTATTTTGGGCTGGAGACCTGGAGTCCTTGAAGGGCATCTGGAGGGGGCCCAAACCTGTCTCTACGTTCCTCCATGAGGCAGTCCAGGCTCCCTGTGCGAGCTTCGTGTCGGTGCTCAGATTCCCCTTGGTGGTGCATGTGGGTGGCTCATCCCTGAGCCCCTGTTCTCCCCTTGTGTCTTTCAGTGAACTCGTTTGCCCAGGAGGACCCCTGGCCTTGAGCAGCATAGGTCAGTGGATCCTACTGGGGTCATGGGCCATGGACCAGGCCACGTGGGGTCACTGAGGGTCAGCTATCAGGACAGGAGGGATTCCTCAGGGAGACAACCTGAATCCCCACTGGTGAGGGATTGGTTCTCCAGAAGGGCCGCCTCCTTGGGAATCTGACCCAAGGAGGACACCTTCCCTGAAGTGCTACAGGAGTGACATTGGTCCAGGCAGGAAAGGGTTCCATTAGTCCCATGCAGGTCAGCTCCCAGCTGAGACTTGGTGCTAGGGTCTGGCCTTGAGGACTGCCCAAGCCACATGAAGGTGGCCCCAGGCTGTGATTTTTGGTGCGTGCTTGGAGAGGGAGTCTGGGCACCCTCCCTGCACAGGGGCAGGCTGTGCGTCTGCCAGGTCTACAGTGGCGCCTAGCTTCAGAGCAAGCT-C Normal pregnancy not provided (-) 157337 15-25278417-C-T Likely benign (Mar 01, 2024) 2498602 15-25338938-T-C Likely benign (Sep 15, 2019) 1189552 15-25339053-A-ATCCC Angelman syndrome Pathogenic (Jun 15, 2004) 7972 15-25339090-CT-C Angelman syndrome Uncertain significance (Feb 14, 2014) 156148 15-25339101-CTTCCTTTTTTTTGT-C Likely benign (Aug 01, 2024) 1217730 15-25339114-G-T Benign (Mar 06, 2020) 1292518 15-25339119-ATTTTG-A Angelman syndrome Likely benign (Jul 14, 2017) 156147 15-25339119-ATTTTGTTTTG-A Conflicting classifications of pathogenicity (May 30, 2018) 597186 15-25339119-ATTTTGTTTTGTTTTG-A Likely benign (Dec 03, 2021) 1201398 15-25339124-GT-G Likely benign (Jan 30, 2018) 1250412 15-25339124-GTTTTGTTTTGTTTTA-G Likely pathogenic (Oct 23, 2020) 987033 15-25339130-TTTTGTTTTAC-T Angelman syndrome Pathogenic (Feb 22, 2016) 155985 15-25339133-T-C Angelman syndrome Uncertain significance (Jun 15, 2023) 597013 15-25339138-T-A Angelman syndrome Pathogenic (Feb 14, 2014) 136203 15-25339138-T-C not specified • Angelman syndrome • UBE3A-related disorder • Inborn genetic diseases Benign (Aug 01, 2024) 96262 15-25339141-AGCATGCCAAATCCTTTGGCATACGTGATGGCCTTCAACAATCTCTCTTTAAGTTTTTCTTTGCTTGAG-A Angelman syndrome Pathogenic (Feb 14, 2014) 155980 15-25339142-G-A Angelman syndrome Likely benign (Aug 06, 2021) 1535240 15-25339147-C-T Angelman syndrome Conflicting classifications of pathogenicity (Jan 15, 2014) 160221 15-25339148-C-CA Angelman syndrome Pathogenic (Feb 08, 2013) 212536 15-25339152-T-A Angelman syndrome Likely benign (Aug 05, 2022) 573621 15-25339151-A-ATCCTT Angelman syndrome Likely pathogenic (Sep 01, 2021) 961399 15-25339158-G-A Inborn genetic diseases Likely benign (May 31, 2017) 589778 15-25339159-GC-G Likely pathogenic (Nov 30, 2016) 425063
Previous Next
GnomAD Source: gnomAD
dbNSFP Source: dbNSFP